Europa Biosite enters Czech market with acquisition of diagnostics distributor
pharmafile.com | November 12, 2026 | News story | |Â Â Â
Europa Biosite has agreed to acquire Czech diagnostics and laboratory technology distributor MEDISTA spol. s r.o., marking its entry into the Czech Republic and strengthening its diagnostics business.
The acquisition is subject to customary regulatory approvals. MEDISTA’s directors, Jan Kadlec and Alexandra Kadlecová, will remain in their respective roles, with Kadlec also joining Europa Biosite’s Group Leadership Team.
MEDISTA distributes products across several diagnostics disciplines, including haematology, biochemistry, transfusion medicine, point-of-care testing, molecular genetics, diabetology and veterinary medicine. The company also provides local customer and technical support.
Europa Biosite said the acquisition would add specialist diagnostics expertise and established customer and supplier relationships to its existing life science distribution businesses across Europe and North America.
The group, led by Chief Executive Officer Claudia Berrón, said it would continue to pursue acquisitions to expand its geographical presence and specialist capabilities.
